APO Research
Talk to an analyst

APO RESEARCH · REPORT

GABA

GABA (γ-aminobutyric acid), CAS 56-12-2, is a four carbon non-protein amino acid that is widely distributed in plants, animals and microorganisms. As a metabolic product of plants and microorganisms produced by the decarboxylation of glutamic acid, GABA functions as an inhibitory neurotransmitter in the brain that directly affects the personality and the stress management. A wide range of traditional foods produced by microbial fermentation contain GABA, in which GABA is safe and eco-friendly, and also has the possibility of providing new health-benefited products enriched with GABA. Synthesis of GABA is catalyzed by glutamate decarboxylase, therefore, the optimal fermentation condition is mainly based on the biochemical properties of the enzyme. Major GABA producing microorganisms are lactic acid bacteria (LAB), which make food spoilage pathogens unable to grow and act as probiotics in the gastrointestinal tract.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

GABA (γ-aminobutyric acid), CAS 56-12-2, is a four carbon non-protein amino acid that is widely distributed in plants, animals and microorganisms. As a metabolic product of plants and microorganisms produced by the decarboxylation of glutamic acid, GABA functions as an inhibitory neurotransmitter in the brain that directly affects the personality and the stress management. A wide range of traditional foods produced by microbial fermentation contain GABA, in which GABA is safe and eco-friendly, and also has the possibility of providing new health-benefited products enriched with GABA. Synthesis of GABA is catalyzed by glutamate decarboxylase, therefore, the optimal fermentation condition is mainly based on the biochemical properties of the enzyme. Major GABA producing microorganisms are lactic acid bacteria (LAB), which make food spoilage pathogens unable to grow and act as probiotics in the gastrointestinal tract.

Selected research

Market Outlook & Growth Opportunities

Global GABA Market Outlook and Growth Opportunities 2026

21 December 2025209 pages

Choose your research edition.

Industry ResearchGABA Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal GABA Industry Growth and Trends Forecast to 2032118 pages · $3,450 USDMarket StructureGlobal GABA Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal GABA Market Outlook and Growth Opportunities 2026209 pages · $4,250 USDMarket Analysis & ForecastGlobal GABA Market Analysis and Forecast 2026-2032213 pages · $4,950 USD

Market perspective

GABA (γ-aminobutyric acid), CAS 56-12-2, is a four carbon non-protein amino acid that is widely distributed in plants, animals and microorganisms. As a metabolic product of plants and microorganisms produced by the decarboxylation of glutamic acid, GABA functions as an inhibitory neurotransmitter in the brain that directly affects the personality and the stress management. A wide range of traditional foods produced by microbial fermentation contain GABA, in which GABA is safe and eco-friendly, and also has the possibility of providing new health-benefited products enriched with GABA. Synthesis of GABA is catalyzed by glutamate decarboxylase, therefore, the optimal fermentation condition is mainly based on the biochemical properties of the enzyme. Major GABA producing microorganisms are lactic acid bacteria (LAB), which make food spoilage pathogens unable to grow and act as probiotics in the gastrointestinal tract.

Global GABA (CAS 56-12-2) key players include Pharma Foods International, Kyowa Hakko, Sekisui Chemical, Sino Biotek, Zhejiang Yiwan Bio, etc. Global top five manufacturers hold a share about 45%. China is the largest market, with a share about 90%, followed by Japan, have a share over 3 percent. In terms of Production, Microbial Fermentation (feed grade) is the largest segment, with a share over 77%. And in terms of Application, the largest application is Food, followed by Medicine, Plant Growth Promoter, etc.

This report provides an overview of the global GABA market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of GABA and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents GABA sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the GABA market size, projected growth trends, production technologies, key applications, and end-use industries.

GABA Segment by Company

Pharma Foods International

Kyowa Hakko

Sekisui Chemical

Sino Biotek

Zhejiang Yiwan Bio

Shanghai Richen

Luckerkong

Qandr Biology

Bloomage Biotech

Jyswkj

Zjtr Chemistry

Xinyou Chemistry

Bornsun Biology

Huarui Biology

Viab Life

Microbiofeed

Harworld

GABA Segment by Type

Microbial Fermentation (Feed Grade)

Microbial Fermentation (Food Grade)

Chemical Synthesis

GABA Segment by Application

Animal Feed

Food

Medicine

Plant Growth Promoter

Cosmetic

Other

GABA Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global GABA status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions GABA market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify GABA significant trends, drivers, influence factors in global and regions.

6. To analyze GABA competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global GABA market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of GABA and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of GABA.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the GABA market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global GABA industry.

Chapter 3: Detailed analysis of GABA manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of GABA in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of GABA in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. GABA Industry Trends Table 2. GABA Industry Drivers Table 3. GABA Industry Opportunities and Challenges Table 4. GABA Industry Restraints Table 5. Global GABA Revenue by Company (US$ Million) & (2021-2026) Table 6. Global GABA Revenue Share by Company (2021-2026) Table 7. Global GABA Sales Volume by Company (Ton) & (2021-2026) Table 8. Global GABA Sales Volume Share by Company (2021-2026) Table 9. Global GABA Average Price (US$/Kg) of Company (2021-2026) Table 10. Global GABA Company Ranking, (2024-2026) & (USD Million) Table 11. Global GABA Key Company Manufacturing Base & Headquarters Table 12. Global GABA Company, Product Type & Application Table 13. Global GABA Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global GABA by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Microbial Fermentation (Feed Grade) Table 18. Significant Companies of Microbial Fermentation (Food Grade) Table 19. Significant Companies of Chemical Synthesis Table 20. Global GABA Sales Volume by Type 2021 VS 2025 VS 2032 (Ton) Table 21. Global GABA Sales Volume by Type (2021-2026) & (Ton) Table 22. Global GABA Sales Volume by Type (2027-2032) & (Ton) Table 23. Global GABA Sales Volume Share by Type (2021-2026) Table 24. Global GABA Sales Volume Share by Type (2027-2032) Table 25. Global GABA Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global GABA Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global GABA Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global GABA Sales Value Share by Type (2021-2026) Table 29. Global GABA Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Animal Feed Table 31. Significant Companies of Food Table 32. Significant Companies of Medicine Table 33. Significant Companies of Plant Growth Promoter Table 34. Significant Companies of Cosmetic Table 35. Significant Companies of Other Table 36. Global GABA Sales Volume by Application 2021 VS 2025 VS 2032 (Ton) Table 37. Global GABA Sales Volume by Application (2021-2026) & (Ton) Table 38. Global GABA Sales Volume by Application (2027-2032) & (Ton) Table 39. Global GABA Sales Volume Share by Application (2021-2026) Table 40. Global GABA Sales Volume Share by Application (2027-2032) Table 41. Global GABA Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 42. Global GABA Sales Value by Application (2021-2026) & (US$ Million) Table 43. Global GABA Sales Value by Application (2027-2032) & (US$ Million) Table 44. Global GABA Sales Value Share by Application (2021-2026) Table 45. Global GABA Sales Value Share by Application (2027-2032) Table 46. Global GABA Sales by Region: 2021 VS 2025 VS 2032 (Ton) Table 47. Global GABA Sales by Region (2021-2026) & (Ton) Table 48. Global GABA Sales Market Share by Region (2021-2026) Table 49. Global GABA Sales by Region (2027-2032) & (Ton) Table 50. Global GABA Sales Market Share by Region (2027-2032) Table 51. Global GABA Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 52. Global GABA Sales Value by Region (2021-2026) & (US$ Million) Table 53. Global GABA Sales Value Share by Region (2021-2026) Table 54. Global GABA Sales Value by Region (2027-2032) & (US$ Million) Table 55. Global GABA Sales Value Share by Region (2027-2032) Table 56. Global GABA Market Average Price (US$/Kg) by Region (2021-2026) Table 57. Global GABA Market Average Price (US$/Kg) by Region (2027-2032) Table 58. Global GABA Sales by Country: 2021 VS 2025 VS 2032 (Ton) Table 59. Global GABA Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global GABA Sales by Country (2021-2026) & (Ton) Table 61. Global GABA Sales Market Share by Country (2021-2026) Table 62. Global GABA Sales by Country (2027-2032) & (Ton) Table 63. Global GABA Sales Market Share by Country (2027-2032) Table 64. Global GABA Sales Value by Country (2021-2026) & (US$ Million) Table 65. Global GABA Sales Value Market Share by Country (2021-2026) Table 66. Global GABA Sales Value by Country (2027-2032) & (US$ Million) Table 67. Global GABA Sales Value Market Share by Country (2027-2032) Table 68. Pharma Foods International Company Information Table 69. Pharma Foods International Business Overview Table 70. Pharma Foods International GABA Sales (Ton), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 71. Pharma Foods International GABA Product Portfolio Table 72. Pharma Foods International Recent Development Table 73. Kyowa Hakko Company Information Table 74. Kyowa Hakko Business Overview Table 75. Kyowa Hakko GABA Sales (Ton), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 76. Kyowa Hakko GABA Product Portfolio Table 77. Kyowa Hakko Recent Development Table 78. Sekisui Chemical Company Information Table 79. Sekisui Chemical Business Overview Table 80. Sekisui Chemical GABA Sales (Ton), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 81. Sekisui Chemical GABA Product Portfolio Table 82. Sekisui Chemical Recent Development Table 83. Sino Biotek Company Information Table 84. Sino Biotek Business Overview Table 85. Sino Biotek GABA Sales (Ton), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 86. Sino Biotek GABA Product Portfolio Table 87. Sino Biotek Recent Development Table 88. Zhejiang Yiwan Bio Company Information Table 89. Zhejiang Yiwan Bio Business Overview Table 90. Zhejiang Yiwan Bio GABA Sales (Ton), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 91. Zhejiang Yiwan Bio GABA Product Portfolio Table 92. Zhejiang Yiwan Bio Recent Development Table 93. Shanghai Richen Company Information Table 94. Shanghai Richen Business Overview Table 95. Shanghai Richen GABA Sales (Ton), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 96. Shanghai Richen GABA Product Portfolio Table 97. Shanghai Richen Recent Development Table 98. Luckerkong Company Information Table 99. Luckerkong Business Overview Table 100. Luckerkong GABA Sales (Ton), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 101. Luckerkong GABA Product Portfolio Table 102. Luckerkong Recent Development Table 103. Qandr Biology Company Information Table 104. Qandr Biology Business Overview Table 105. Qandr Biology GABA Sales (Ton), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 106. Qandr Biology GABA Product Portfolio Table 107. Qandr Biology Recent Development Table 108. Bloomage Biotech Company Information Table 109. Bloomage Biotech Business Overview Table 110. Bloomage Biotech GABA Sales (Ton), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 111. Bloomage Biotech GABA Product Portfolio Table 112. Bloomage Biotech Recent Development Table 113. Jyswkj Company Information Table 114. Jyswkj Business Overview Table 115. Jyswkj GABA Sales (Ton), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 116. Jyswkj GABA Product Portfolio Table 117. Jyswkj Recent Development Table 118. Zjtr Chemistry Company Information Table 119. Zjtr Chemistry Business Overview Table 120. Zjtr Chemistry GABA Sales (Ton), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 121. Zjtr Chemistry GABA Product Portfolio Table 122. Zjtr Chemistry Recent Development Table 123. Xinyou Chemistry Company Information Table 124. Xinyou Chemistry Business Overview Table 125. Xinyou Chemistry GABA Sales (Ton), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 126. Xinyou Chemistry GABA Product Portfolio Table 127. Xinyou Chemistry Recent Development Table 128. Bornsun Biology Company Information Table 129. Bornsun Biology Business Overview Table 130. Bornsun Biology GABA Sales (Ton), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 131. Bornsun Biology GABA Product Portfolio Table 132. Bornsun Biology Recent Development Table 133. Huarui Biology Company Information Table 134. Huarui Biology Business Overview Table 135. Huarui Biology GABA Sales (Ton), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 136. Huarui Biology GABA Product Portfolio Table 137. Huarui Biology Recent Development Table 138. Viab Life Company Information Table 139. Viab Life Business Overview Table 140. Viab Life GABA Sales (Ton), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 141. Viab Life GABA Product Portfolio Table 142. Viab Life Recent Development Table 143. Microbiofeed Company Information Table 144. Microbiofeed Business Overview Table 145. Microbiofeed GABA Sales (Ton), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 146. Microbiofeed GABA Product Portfolio Table 147. Microbiofeed Recent Development Table 148. Harworld Company Information Table 149. Harworld Business Overview Table 150. Harworld GABA Sales (Ton), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 151. Harworld GABA Product Portfolio Table 152. Harworld Recent Development Table 153. Key Raw Materials Table 154. Raw Materials Key Suppliers Table 155. GABA Distributors List Table 156. GABA Customers List Table 157. Research Programs/Design for This Report Table 158. Authors List of This Report Table 159. Secondary Sources Table 160. Primary Sources List of Figures Figure 1. GABA Product Image Figure 2. Global GABA Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global GABA Sales Value (2021-2032) & (US$ Million) Figure 4. Global GABA Sales (2021-2032) & (Ton) Figure 5. Global GABA Sales Average Price (US$/Kg) & (2021-2032) Figure 6. Global GABA Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Microbial Fermentation (Feed Grade) Image Figure 10. Microbial Fermentation (Food Grade) Image Figure 11. Chemical Synthesis Image Figure 12. Global GABA Sales Volume by Type (2021 VS 2025 VS 2032) & (Ton) Figure 13. Global GABA Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global GABA Sales Volume Share by Type (2021-2032) Figure 15. Global GABA Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global GABA Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global GABA Sales Value Share by Type (2021-2032) Figure 18. Animal Feed Image Figure 19. Food Image Figure 20. Medicine Image Figure 21. Plant Growth Promoter Image Figure 22. Cosmetic Image Figure 23. Other Image Figure 24. Global GABA Sales Volume by Application (2021 VS 2025 VS 2032) & (Ton) Figure 25. Global GABA Sales Volume Share 2021 VS 2025 VS 2032 Figure 26. Global GABA Sales Volume Share by Application (2021-2032) Figure 27. Global GABA Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global GABA Sales Value Share 2021 VS 2025 VS 2032 Figure 29. Global GABA Sales Value Share by Application (2021-2032) Figure 30. Global GABA Sales by Region: 2021 VS 2025 VS 2032 (Ton) Figure 31. Global GABA Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 32. Global GABA Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 33. Global GABA Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 34. North America GABA Sales Value (2021-2032) & (US$ Million) Figure 35. North America GABA Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Europe GABA Sales Value (2021-2032) & (US$ Million) Figure 37. Europe GABA Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Asia-Pacific GABA Sales Value (2021-2032) & (US$ Million) Figure 39. Asia-Pacific GABA Sales Value Share by Country (%), 2025 VS 2032 Figure 40. South America GABA Sales Value (2021-2032) & (US$ Million) Figure 41. South America GABA Sales Value Share by Country (%), 2025 VS 2032 Figure 42. Middle East & Africa GABA Sales Value (2021-2032) & (US$ Million) Figure 43. Middle East & Africa GABA Sales Value Share by Country (%), 2025 VS 2032 Figure 44. USA GABA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. USA GABA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. USA GABA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Canada GABA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Canada GABA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Canada GABA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Mexico GABA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Mexico GABA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Mexico GABA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Germany GABA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Germany GABA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Germany GABA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. France GABA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. France GABA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. France GABA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. U.K. GABA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. U.K. GABA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. U.K. GABA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Italy GABA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Italy GABA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Italy GABA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Spain GABA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Spain GABA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Spain GABA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Russia GABA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Russia GABA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Russia GABA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Netherlands GABA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Netherlands GABA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Netherlands GABA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Nordic Countries GABA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Nordic Countries GABA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Nordic Countries GABA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. China GABA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. China GABA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. China GABA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Japan GABA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Japan GABA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Japan GABA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. South Korea GABA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. South Korea GABA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. South Korea GABA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. India GABA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. India GABA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. India GABA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Australia GABA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Australia GABA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Australia GABA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Southeast Asia GABA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Southeast Asia GABA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Southeast Asia GABA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Brazil GABA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Brazil GABA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Brazil GABA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Argentina GABA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Argentina GABA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Argentina GABA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Chile GABA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Chile GABA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Chile GABA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Colombia GABA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Colombia GABA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Colombia GABA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Peru GABA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Peru GABA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Peru GABA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Saudi Arabia GABA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Saudi Arabia GABA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Saudi Arabia GABA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Israel GABA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Israel Arabia GABA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Israel Arabia GABA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. UAE GABA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. UAE GABA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. UAE GABA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Turkey GABA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Turkey GABA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Turkey GABA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Iran GABA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Iran GABA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Iran GABA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Egypt GABA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 126. Egypt GABA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 127. Egypt GABA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 128. GABA Value Chain Figure 129. Manufacturing Cost Structure Figure 130. GABA Sales Mode & Process Figure 131. Direct Comparison with Distribution Share Figure 132. Distributors Profiles Figure 133. Years Considered Figure 134. Research Process Figure 135. Key Executives Interviewed

Scope & coverage.

Types
  • Microbial Fermentation (Feed Grade)
  • Microbial Fermentation (Food Grade)
  • Chemical Synthesis
Applications
  • Animal Feed
  • Food
  • Medicine
  • Plant Growth Promoter
  • Cosmetic
  • Other
Companies covered
  • Pharma Foods International
  • Kyowa Hakko
  • Sekisui Chemical
  • Sino Biotek
  • Zhejiang Yiwan Bio
  • Shanghai Richen
  • Luckerkong
  • Qandr Biology
  • Bloomage Biotech
  • Jyswkj
  • Zjtr Chemistry
  • Xinyou Chemistry
  • Bornsun Biology
  • Huarui Biology
  • Viab Life
  • Microbiofeed
  • Harworld

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global GABA Sales Value (2021-2032)
  4. 1.2.2 Global GABA Sales Volume (2021-2032)
  5. 1.2.3 Global GABA Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 GABA Market Dynamics
  1. 2.1 GABA Industry Trends
  2. 2.2 GABA Industry Drivers
  3. 2.3 GABA Industry Opportunities and Challenges
  4. 2.4 GABA Industry Restraints
3 GABA Market by Company
  1. 3.1 Global GABA Company Revenue Ranking in 2025
  2. 3.2 Global GABA Revenue by Company (2021-2026)
  3. 3.3 Global GABA Sales Volume by Company (2021-2026)
  4. 3.4 Global GABA Average Price by Company (2021-2026)
  5. 3.5 Global GABA Company Ranking (2024-2026)
  6. 3.6 Global GABA Company Manufacturing Base and Headquarters
  7. 3.7 Global GABA Company Product Type and Application
  8. 3.8 Global GABA Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global GABA Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 GABA Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 GABA Market by Type
  1. 4.1 GABA Type Introduction
  2. 4.1.1 Microbial Fermentation (Feed Grade)
  3. 4.1.2 Microbial Fermentation (Food Grade)
  4. 4.1.3 Chemical Synthesis
  5. 4.2 Global GABA Sales Volume by Type
  6. 4.2.1 Global GABA Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global GABA Sales Volume by Type (2021-2032)
  8. 4.2.3 Global GABA Sales Volume Share by Type (2021-2032)
  9. 4.3 Global GABA Sales Value by Type
  10. 4.3.1 Global GABA Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global GABA Sales Value by Type (2021-2032)
  12. 4.3.3 Global GABA Sales Value Share by Type (2021-2032)
5 GABA Market by Application
  1. 5.1 GABA Application Introduction
  2. 5.1.1 Animal Feed
  3. 5.1.2 Food
  4. 5.1.3 Medicine
  5. 5.1.4 Plant Growth Promoter
  6. 5.1.5 Cosmetic
  7. 5.1.6 Other
  8. 5.2 Global GABA Sales Volume by Application
  9. 5.2.1 Global GABA Sales Volume by Application (2021 VS 2025 VS 2032)
  10. 5.2.2 Global GABA Sales Volume by Application (2021-2032)
  11. 5.2.3 Global GABA Sales Volume Share by Application (2021-2032)
  12. 5.3 Global GABA Sales Value by Application
  13. 5.3.1 Global GABA Sales Value by Application (2021 VS 2025 VS 2032)
  14. 5.3.2 Global GABA Sales Value by Application (2021-2032)
  15. 5.3.3 Global GABA Sales Value Share by Application (2021-2032)
6 GABA Regional Sales and Value Analysis
  1. 6.1 Global GABA Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global GABA Sales by Region (2021-2032)
  3. 6.2.1 Global GABA Sales by Region: 2021-2026
  4. 6.2.2 Global GABA Sales by Region (2027-2032)
  5. 6.3 Global GABA Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global GABA Sales Value by Region (2021-2032)
  7. 6.4.1 Global GABA Sales Value by Region: 2021-2026
  8. 6.4.2 Global GABA Sales Value by Region (2027-2032)
  9. 6.5 Global GABA Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America GABA Sales Value (2021-2032)
  12. 6.6.2 North America GABA Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe GABA Sales Value (2021-2032)
  15. 6.7.2 Europe GABA Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific GABA Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific GABA Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America GABA Sales Value (2021-2032)
  21. 6.9.2 South America GABA Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa GABA Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa GABA Sales Value Share by Country, 2025 VS 2032
7 GABA Country-level Sales and Value Analysis
  1. 7.1 Global GABA Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global GABA Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global GABA Sales by Country (2021-2032)
  4. 7.3.1 Global GABA Sales by Country (2021-2026)
  5. 7.3.2 Global GABA Sales by Country (2027-2032)
  6. 7.4 Global GABA Sales Value by Country (2021-2032)
  7. 7.4.1 Global GABA Sales Value by Country (2021-2026)
  8. 7.4.2 Global GABA Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA GABA Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA GABA Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA GABA Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada GABA Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada GABA Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada GABA Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico GABA Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico GABA Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico GABA Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany GABA Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany GABA Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany GABA Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France GABA Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France GABA Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France GABA Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. GABA Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. GABA Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. GABA Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy GABA Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy GABA Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy GABA Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain GABA Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain GABA Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain GABA Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia GABA Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia GABA Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia GABA Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands GABA Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands GABA Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands GABA Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries GABA Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries GABA Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries GABA Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China GABA Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China GABA Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China GABA Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan GABA Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan GABA Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan GABA Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea GABA Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea GABA Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea GABA Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India GABA Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India GABA Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India GABA Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia GABA Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia GABA Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia GABA Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia GABA Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia GABA Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia GABA Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil GABA Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil GABA Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil GABA Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina GABA Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina GABA Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina GABA Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile GABA Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile GABA Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile GABA Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia GABA Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia GABA Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia GABA Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru GABA Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru GABA Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru GABA Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia GABA Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia GABA Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia GABA Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel GABA Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel GABA Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel GABA Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE GABA Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE GABA Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE GABA Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey GABA Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey GABA Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey GABA Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran GABA Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran GABA Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran GABA Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt GABA Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt GABA Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt GABA Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Pharma Foods International
  2. 8.1.1 Pharma Foods International Company Information
  3. 8.1.2 Pharma Foods International Business Overview
  4. 8.1.3 Pharma Foods International GABA Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Pharma Foods International GABA Product Portfolio
  6. 8.1.5 Pharma Foods International Recent Developments
  7. 8.2 Kyowa Hakko
  8. 8.2.1 Kyowa Hakko Company Information
  9. 8.2.2 Kyowa Hakko Business Overview
  10. 8.2.3 Kyowa Hakko GABA Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Kyowa Hakko GABA Product Portfolio
  12. 8.2.5 Kyowa Hakko Recent Developments
  13. 8.3 Sekisui Chemical
  14. 8.3.1 Sekisui Chemical Company Information
  15. 8.3.2 Sekisui Chemical Business Overview
  16. 8.3.3 Sekisui Chemical GABA Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Sekisui Chemical GABA Product Portfolio
  18. 8.3.5 Sekisui Chemical Recent Developments
  19. 8.4 Sino Biotek
  20. 8.4.1 Sino Biotek Company Information
  21. 8.4.2 Sino Biotek Business Overview
  22. 8.4.3 Sino Biotek GABA Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Sino Biotek GABA Product Portfolio
  24. 8.4.5 Sino Biotek Recent Developments
  25. 8.5 Zhejiang Yiwan Bio
  26. 8.5.1 Zhejiang Yiwan Bio Company Information
  27. 8.5.2 Zhejiang Yiwan Bio Business Overview
  28. 8.5.3 Zhejiang Yiwan Bio GABA Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Zhejiang Yiwan Bio GABA Product Portfolio
  30. 8.5.5 Zhejiang Yiwan Bio Recent Developments
  31. 8.6 Shanghai Richen
  32. 8.6.1 Shanghai Richen Company Information
  33. 8.6.2 Shanghai Richen Business Overview
  34. 8.6.3 Shanghai Richen GABA Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Shanghai Richen GABA Product Portfolio
  36. 8.6.5 Shanghai Richen Recent Developments
  37. 8.7 Luckerkong
  38. 8.7.1 Luckerkong Company Information
  39. 8.7.2 Luckerkong Business Overview
  40. 8.7.3 Luckerkong GABA Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Luckerkong GABA Product Portfolio
  42. 8.7.5 Luckerkong Recent Developments
  43. 8.8 Qandr Biology
  44. 8.8.1 Qandr Biology Company Information
  45. 8.8.2 Qandr Biology Business Overview
  46. 8.8.3 Qandr Biology GABA Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Qandr Biology GABA Product Portfolio
  48. 8.8.5 Qandr Biology Recent Developments
  49. 8.9 Bloomage Biotech
  50. 8.9.1 Bloomage Biotech Company Information
  51. 8.9.2 Bloomage Biotech Business Overview
  52. 8.9.3 Bloomage Biotech GABA Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Bloomage Biotech GABA Product Portfolio
  54. 8.9.5 Bloomage Biotech Recent Developments
  55. 8.10 Jyswkj
  56. 8.10.1 Jyswkj Company Information
  57. 8.10.2 Jyswkj Business Overview
  58. 8.10.3 Jyswkj GABA Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Jyswkj GABA Product Portfolio
  60. 8.10.5 Jyswkj Recent Developments
  61. 8.11 Zjtr Chemistry
  62. 8.11.1 Zjtr Chemistry Company Information
  63. 8.11.2 Zjtr Chemistry Business Overview
  64. 8.11.3 Zjtr Chemistry GABA Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Zjtr Chemistry GABA Product Portfolio
  66. 8.11.5 Zjtr Chemistry Recent Developments
  67. 8.12 Xinyou Chemistry
  68. 8.12.1 Xinyou Chemistry Company Information
  69. 8.12.2 Xinyou Chemistry Business Overview
  70. 8.12.3 Xinyou Chemistry GABA Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Xinyou Chemistry GABA Product Portfolio
  72. 8.12.5 Xinyou Chemistry Recent Developments
  73. 8.13 Bornsun Biology
  74. 8.13.1 Bornsun Biology Company Information
  75. 8.13.2 Bornsun Biology Business Overview
  76. 8.13.3 Bornsun Biology GABA Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Bornsun Biology GABA Product Portfolio
  78. 8.13.5 Bornsun Biology Recent Developments
  79. 8.14 Huarui Biology
  80. 8.14.1 Huarui Biology Company Information
  81. 8.14.2 Huarui Biology Business Overview
  82. 8.14.3 Huarui Biology GABA Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Huarui Biology GABA Product Portfolio
  84. 8.14.5 Huarui Biology Recent Developments
  85. 8.15 Viab Life
  86. 8.15.1 Viab Life Company Information
  87. 8.15.2 Viab Life Business Overview
  88. 8.15.3 Viab Life GABA Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Viab Life GABA Product Portfolio
  90. 8.15.5 Viab Life Recent Developments
  91. 8.16 Microbiofeed
  92. 8.16.1 Microbiofeed Company Information
  93. 8.16.2 Microbiofeed Business Overview
  94. 8.16.3 Microbiofeed GABA Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Microbiofeed GABA Product Portfolio
  96. 8.16.5 Microbiofeed Recent Developments
  97. 8.17 Harworld
  98. 8.17.1 Harworld Company Information
  99. 8.17.2 Harworld Business Overview
  100. 8.17.3 Harworld GABA Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Harworld GABA Product Portfolio
  102. 8.17.5 Harworld Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 GABA Value Chain Analysis
  2. 9.1.1 GABA Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 GABA Sales Mode & Process
  6. 9.2 GABA Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 GABA Distributors
  9. 9.2.3 GABA Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst